IHME logo
Loading...

Aleksandr Aravkin

Director, Mathematical Sciences; Adjunct Associate Professor

Aleksandr (Sasha) Aravkin, PhD, MS, is Associate Professor in the Department of Applied Mathematics and Adjunct Associate Professor of Health Metrics Sciences, Mathematics, and Statistics, and Director of Mathematical Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. At IHME, Dr. Aravkin contributes to the strategic direction of the application, uptake, and expansion of mathematical sciences applied to cross-cutting analytic challenges at IHME and seeks out strategic partnerships and opportunities that would enhance IHME’s ability to create innovative science and solve persistent data and analytic challenges using mathematical sciences. He also leads the Mathematical Sciences and Computational Algorithms team at IHME.

Dr. Aravkin’s work focuses on large scale optimization, machine learning and data science. Dr. Aravkin has been working with IHME to develop the Evidence Score model, which requires the development and implementation of entirely new modes and algorithms, as well as emerging methodologies. His work on fusing physics-based and data-driven models allows him to collaborate broadly across campus, as well as with researchers in many universities and in industry.

Dr. Aravkin earned a PhD in Mathematics and MS in Statistics from University of Washington.

IHME was established at the University of Washington in Seattle in 2007. Its mission is to deliver to the world timely, relevant, and scientifically valid evidence to improve health policy and practice.

Publications

Showing 1 - 5 of 66 results
He J, Flaxman A, Imai-Eaton JW, et al. Association Between Early Sexual Debut and New HIV Infections Among Adolescents and Young Adults in 11 African Countries. AIDS and Behavior. 15 June 2024. doi: 10.1007/s10461-024-04343-w.
GBD 2021 Global Stillbirths Collaborators. Global, regional, and national stillbirths at 20 weeks’ gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021. The Lancet. 4 November 2024. doi: 10.1016/S0140-6736(24)01925-1.
GBD 2021 Pulmonary Arterial Hypertension Collaborators. Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine. 18 October 2024. doi: 10.1016/S2213-2600(24)00295-9.
Vision Loss Expert Group of the Global Burden of Disease Study & the GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020. Eye. 4 July 2024. doi: 10.1038/s41433-024-03106-0.
Vision Loss Expert Group of the Global Burden of Disease Study & the GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 2000 to 2020. Eye. 27 June 2024. doi: 10.1038/s41433-024-03101-5.